SCHEMBL370103

SCHEMBL370103

CCCCC(=O)Oc1ccc(I)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.52
MAPT P10636 2/20 0.52
HSD17B10 Q99714 2/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
BCL9 O00512 1/20 0.49
CTNNB1 P35222 1/20 0.49
MEN1 O00255 3/20 0.47
RECQL P46063 2/20 0.47
KDM4E B2RXH2 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.44
ESR1 P03372 2/20 0.43
HIF1A Q16665 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
TP53 P04637 1/20 0.42
SLC22A2 O15244 1/20 0.41
TMPRSS2 O15393 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27730064 0.95 KMT2A (0.57) KMT2AMAPTHSD17B10ALDH1A1LMNA
SCHEMBL31150525 0.93 KMT2A (0.59) KMT2AMAPTHSD17B10ALDH1A1LMNA
SCHEMBL27546335 0.93 KMT2A (0.59) KMT2AMAPTHSD17B10ALDH1A1LMNA
SCHEMBL16546594 0.93 KMT2A (0.59) KMT2AMAPTHSD17B10ALDH1A1LMNA
SCHEMBL5822065 0.91 KMT2A (0.61) KMT2AMAPTHSD17B10ALDH1A1LMNA
SCHEMBL2242019 0.89 BCL9 (0.60) KMT2AMAPTHSD17B10ALDH1A1LMNA
SCHEMBL15549194 0.85 KMT2A (0.66) KMT2AMAPTHSD17B10ALDH1A1LMNA
SCHEMBL10407329 0.85 KMT2A (0.65) KMT2AMAPTHSD17B10ALDH1A1LMNA
SCHEMBL7500294 0.84 KMT2A (0.58) KMT2AMAPTHSD17B10ALDH1A1LMNA
SCHEMBL633267 0.84 HSD17B3 (0.55) KMT2AMAPTHSD17B10ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668599-A1 SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS Inflazome Limited (IE) 2020-06-24 EP disclosed
WO-2019034690-A1 SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS INFLAZOME LIMITED (IE) 2019-02-21 WO disclosed
EP-2593427-A1 SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN Pfizer Limited (GB) 2013-05-22 EP disclosed
WO-2012007883-A1 SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN PFIZER LIMITED (GB) 2012-01-19 WO disclosed
US-7976959-B2 Organic electroluminescent element including bibenzothiopene containing organic compound and display device including the same FUJI XEROX CO., LTD. (JP) 2011-07-12 US disclosed
US-20090243469-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY DEVICE INCLUDING THE SAME FUJI XEROX CO., LTD. (JP) 2009-10-01 US disclosed
EP-1725541-A2 REACTIVE MESOGENIC CHARGE TRANSPORT COMPOUNDS CONTAINING AT LEAST TWO THIOPHENE GROUPS MERCK PATENT GmbH (DE) 2006-11-29 EP disclosed
WO-2005080369-A2 REACTIVE MESOGENIC CHARGE TRANSPORT COMPOUNDS CONTAINING AT LEAST TWO THIOPHENE GROUPS MERCK PATENT GMBH (DE) 2005-09-01 WO disclosed
CN-1028174-C Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity ALLERGAN INC (US) 1995-04-12 CN disclosed
CN-1050385-A Preparation has bioactive method and the intermediate that has the compound of disubstituted acetylene moiety of retinoic acid-like ALLERGAN INC (US) 1991-04-03 CN disclosed